13F-HR filed by SECTOR GAMMA AS
SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-05, with 34 holding rows worth $591,849,000.
- Accession
- 0001567619-19-020408
- Filer
- CIK 1475373
- Filed
- 2019-11-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2019
A holdings report, 34 entries on the cover page, a total value of $591,849,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $591,849,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 110122108 | COM | 1,386,722 | $70,321,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,108,336 | $45,098,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 537,260 | $44,953,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 472,305 | $41,313,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 475,056 | $30,109,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 468,258 | $29,678,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 345,893 | $25,676,000 | thousands by filing date | |
| REVVITY INC | 714046109 | COM | 300,198 | $25,568,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 75,835 | $21,037,000 | thousands by filing date | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 260,293 | $19,946,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 74,607 | $17,913,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 152,105 | $17,010,000 | thousands by filing date | |
| QIAGEN NV | N72482123 | SHS NEW | 484,601 | $15,977,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 46,368 | $15,428,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 257,844 | $14,411,000 | thousands by filing date | |
| TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS | 874060205 | ADR | 816,299 | $14,040,000 | thousands by filing date | |
| BRUKER CORP | 116794108 | COM | 308,004 | $13,531,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 52,426 | $12,206,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 148,147 | $11,815,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 43,999 | $11,249,000 | thousands by filing date | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 417,042 | $11,089,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 64,742 | $9,630,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 429,677 | $9,504,000 | thousands by filing date | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 197,299 | $9,311,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 89,964 | $8,811,000 | thousands by filing date | |
| PATTERSON COS INC | 703395103 | COM | 469,255 | $8,362,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 131,514 | $7,879,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 96,900 | $7,793,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 172,978 | $7,400,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 121,402 | $4,106,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 125,925 | $3,377,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 102,913 | $3,334,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 251,698 | $2,278,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 431,425 | $1,696,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-19-020408 | this filing | 2019-11-05 | acceptance time not in the bulk data set |